{"transactions":[{"id":1096,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T21:40:16.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan,  100 percent will vest on August 30, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026."}],"balance_after":3002,"source":{"system":"sec-edgar","filing":"0001634368-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1634368/000163436826000003/ownership.xml","form_type":"4"}},{"id":1624598,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T21:29:33.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000013","document":"wk-form4_1708637336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000013/wk-form4_1708637336.xml","form_type":"4"}},{"id":2061692,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T22:44:25.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024"}],"balance_after":1788,"source":{"system":"sec-edgar","filing":"0001615219-23-000006","document":"wf-form4_167295864858566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521923000006/wf-form4_167295864858566.xml","form_type":"4"}},{"id":2239880,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:33:19.000Z","date":"2022-06-06","kind":"purchase","acquired":true,"shares":26553,"price":0.1883,"value":4999.9299,"ownership":{"direct":false,"nature":"McVicar Family Trust"},"balance_after":26553,"source":{"system":"sec-edgar","filing":"0001615219-22-000097","document":"wf-form4_165463398025988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000097/wf-form4_165463398025988.xml","form_type":"4"}},{"id":2428520,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T21:09:04.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.48,"exercise_date":"2023-01-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-22-000009","document":"wf-form4_164279932976878.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000009/wf-form4_164279932976878.xml","form_type":"4"}},{"id":2956219,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T22:03:59.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.74,"exercise_date":"2021-12-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000121","document":"wf-form4_160711942230730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000121/wf-form4_160711942230730.xml","form_type":"4"}},{"id":3194957,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T22:04:18.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted are fully vested on March 23, 2021."}],"balance_after":6000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Stock Option (right to buy)","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001615219-20-000030","document":"wf-form4_158517384022844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000030/wf-form4_158517384022844.xml","form_type":"4"}},{"id":3273353,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2020-02-14T02:02:53.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":8700,"price":0.01,"value":87.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock."}],"balance_after":8700,"derivative":{"exercise_price":1.15,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0000899243-20-004561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000089924320004561/doc4.xml","form_type":"4"}},{"id":3276186,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T02:36:32.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":8700,"price":1.15,"value":10005.0,"ownership":{"direct":true},"balance_after":8700,"source":{"system":"sec-edgar","filing":"0000899243-20-004422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000089924320004422/doc4.xml","form_type":"4"}},{"id":3415898,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-13T01:58:15.000Z","date":"2019-09-10","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 19, 2019, the Issuer effected a 1-for-25 reverse stock split of its then outstanding common stock, resulting in the reporting person's ownership of 34,385 options."}],"balance_after":3000,"derivative":{"exercise_price":8,"exercise_date":"2019-12-31","expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001615219-19-000031","document":"wf-form4_156833987897245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521919000031/wf-form4_156833987897245.xml","form_type":"4"}},{"id":3890273,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-18T20:08:44.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":359696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 48 successive equal monthly installments measured from June 14, 2018."}],"balance_after":359696,"derivative":{"exercise_price":1.35,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":359696},"source":{"system":"sec-edgar","filing":"0001615219-18-000037","document":"wf-form4_152935250734695.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521918000037/wf-form4_152935250734695.xml","form_type":"4"}},{"id":4094305,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-19T15:24:38.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 48 successive equal monthly installments measured from January 17, 2018."}],"balance_after":250000,"derivative":{"exercise_price":3.98,"expiration_date":"2028-01-17","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001615219-18-000007","document":"wf-form4_151637546439092.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521918000007/wf-form4_151637546439092.xml","form_type":"4"}},{"id":4249868,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-27T12:52:32.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 48 successive equal monthly installments measured from July 3, 2017."}],"balance_after":50000,"derivative":{"exercise_price":4.08,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001615219-17-000053","document":"wf-form4_150115993838604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521917000053/wf-form4_150115993838604.xml","form_type":"4"}},{"id":4300929,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Stock Option (right to buy)","published_at":"2017-05-30T16:55:21.000Z","date":"2017-05-26","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total shares underlying this option vest on April 5, 2018 and the remaining shares vest 1/48 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":3.37,"expiration_date":"2027-05-26","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001615219-17-000034","document":"wf-form4_149616330679650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521917000034/wf-form4_149616330679650.xml","form_type":"4"}}]}